Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

Compare

9.85

+0.07 (0.72%)

At close: Dec 5, 2025, 4:00 PM EST

9.89

+0.04 (0.41%)

After-hours: Dec 5, 2025, 7:34 PM EST

Telix Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	664.23	484.69	342.57	108.81	5.52	4.02	Upgrade
Revenue Growth (YoY)	55.35%	41.49%	214.82%	1870.12%	37.33%	64.26%	Upgrade
Cost of Revenue	305.95	185.2	134.99	44.29	1.85	1.56	Upgrade
Gross Profit	358.28	299.49	207.58	64.52	3.67	2.46	Upgrade
Selling, General & Admin	168.71	128.18	84.72	59.2	34.16	18.88	Upgrade
Research & Development	153.75	120.45	87.62	55.06	24.82	17.81	Upgrade
Other Operating Expenses	7.72	0.18	-0.13	0.63	-	-	Upgrade
Operating Expenses	330.18	248.81	172.21	114.89	62.75	40.46	Upgrade
Operating Income	28.1	50.68	35.37	-50.37	-59.08	-38	Upgrade
Interest Expense	-10.64	-4.48	-0.53	-0.22	-0.12	-0.15	Upgrade
Interest & Investment Income	9.84	6.72	0.69	0	-	0.05	Upgrade
Currency Exchange Gain (Loss)	13.4	11.58	-0.66	-0.76	1.23	-3.04	Upgrade
Other Non Operating Income (Expenses)	-19.57	-18.37	-8.85	-4.33	10.25	9.34	Upgrade
EBT Excluding Unusual Items	21.14	46.12	26.02	-55.68	-47.71	-31.79	Upgrade
Merger & Restructuring Charges	-5.36	-5.06	-	-	-	-	Upgrade
Asset Writedown	0.5	0.48	-0.55	-	-	-	Upgrade
Other Unusual Items	-7.24	-6.85	-23.36	-11.36	-10.8	-5.19	Upgrade
Pretax Income	9.04	34.69	2.1	-67.03	-58.51	-36.98	Upgrade
Income Tax Expense	-1.8	3.8	-1.45	3.71	0.03	-2.35	Upgrade
Net Income	10.84	30.89	3.55	-70.74	-58.54	-34.63	Upgrade
Net Income to Common	10.84	30.89	3.55	-70.74	-58.54	-34.63	Upgrade
Net Income Growth	-66.76%	769.68%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	254	331	319	311	282	257	Upgrade
Shares Outstanding (Diluted)	260	345	324	311	282	257	Upgrade
Shares Change (YoY)	-37.99%	6.64%	4.21%	10.08%	9.69%	10.21%	Upgrade
EPS (Basic)	0.04	0.09	0.01	-0.23	-0.21	-0.13	Upgrade
EPS (Diluted)	0.04	0.09	0.01	-0.23	-0.21	-0.14	Upgrade
EPS Growth	-45.24%	715.36%	-	-	-	-	Upgrade
Free Cash Flow	9.64	17.77	9.68	-48.26	-44.11	1.32	Upgrade
Free Cash Flow Per Share	0.04	0.05	0.03	-0.15	-0.16	0.01	Upgrade
Gross Margin	53.94%	61.79%	60.60%	59.29%	66.46%	61.17%	Upgrade
Operating Margin	4.23%	10.46%	10.32%	-46.29%	-1069.60%	-944.81%	Upgrade
Profit Margin	1.63%	6.37%	1.04%	-65.01%	-1059.90%	-861.06%	Upgrade
Free Cash Flow Margin	1.45%	3.67%	2.83%	-44.35%	-798.67%	32.84%	Upgrade
EBITDA	36.41	54.2	38.97	-47.3	-55.79	-34.67	Upgrade
EBITDA Margin	5.48%	11.18%	11.38%	-43.47%	-	-	Upgrade
D&A For EBITDA	8.31	3.52	3.6	3.07	3.29	3.33	Upgrade
EBIT	28.1	50.68	35.37	-50.37	-59.08	-38	Upgrade
EBIT Margin	4.23%	10.46%	10.32%	-46.29%	-	-	Upgrade
Effective Tax Rate	-	10.95%	-	-	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q